-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DfZ0WVycLDPJUjXZX43Yh2J4As2+GxEzFFo+4Q198dWCuH7H/NQcosNCcTKFKR9w e+wnNOiQO8er96UJdua0bQ== 0001047469-04-035648.txt : 20041201 0001047469-04-035648.hdr.sgml : 20041201 20041201164737 ACCESSION NUMBER: 0001047469-04-035648 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20041124 ITEM INFORMATION: Changes in Registrant.s Certifying Accountant ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20041201 DATE AS OF CHANGE: 20041201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ISONICS CORP CENTRAL INDEX KEY: 0001023966 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 770338561 STATE OF INCORPORATION: CA FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12531 FILM NUMBER: 041177954 BUSINESS ADDRESS: STREET 1: 5906 MCINTYRE STREET CITY: GOLDEN STATE: CO ZIP: 80403 BUSINESS PHONE: 3032797900 MAIL ADDRESS: STREET 1: 5906 MCINTYRE STREET CITY: GOLDEN STATE: CO ZIP: 80403 8-K 1 a2147650z8-k.htm 8-K
QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report: November 24, 2004

ISONICS CORPORATION
(Name of small business issuer as specified in its charter)

California		001-12531		77-0338561
State of Incorporation		Commission File Number		IRS Employer Identification No.

5906 McIntyre Street, Golden, Colorado 80403
Address of principal executive offices

303-279-7900
Telephone number, including Area code

Not applicable
Former name or former address if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o: Written communications pursuant to Rule 425 under the Securities Act
o: Soliciting material pursuant to Rule 14a-12 under the Exchange Act
o: Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
o: Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

Item 4.01 Changes in Registrant's Certifying Accountant

On November 24, 2004, the Audit Committee of Isonics Corporation (the "Company" or "we"), informed Grant Thornton LLP ("Grant Thornton") that it has dismissed Grant Thornton as the Company's independent registered public accounting firm effective immediately.

On November 24, 2004, the Audit Committee informed Hein & Associates LLP, certified public accountants, that such firm was appointed as the Company's independent registered public accounting firm effective immediately. The Company has authorized Grant Thornton to respond fully to inquiries by our new auditors in connection with the retention of the new auditors.

Grant Thornton's reports on the Company's financial statements for the fiscal years ended April 30, 2003 and 2004 did not contain an adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principle, except for the matter discussed in the next sentence. There was an explanatory paragraph in Grant Thornton's report on the Company's financial statements included in Form 10-KSB for the year ended April 30, 2003, indicating that the accompanying consolidated financial statements had been prepared assuming that the Company will continue as a going concern, and Grant Thornton identified certain factors that raised substantial doubt about the Company's ability to continue as a going concern. That explanatory paragraph was not contained in Grant Thornton's report on the Company's financial statements included in the Company's Form 10-KSB for the year ended April 30, 2004.

In connection with the audits of the Company's financial statements for each of the last two fiscal years ended April 30, 2004 and 2003, and as of November 24, 2004, there were no disagreements between the Company and Grant Thornton on any matter of accounting principles or practices, consolidated financial statement disclosures, or auditing scope and procedures, which, if not resolved to the satisfaction of Grant Thornton, would have caused them to make a reference thereto in connection with their report on the financial statements, except for the following disagreement regarding auditing scope and procedures: Grant Thornton informed the Company that they required additional auditing procedures to be performed with respect to the inquiry being performed by the NASDAQ Listing Investigation Unit (hereinafter the "the NASDAQ inquiry") which commenced in October 2004 and that they needed to obtain additional information from the NASDAQ regarding the NASDAQ inquiry prior to issuing a consent allowing the inclusion, within a Form SB-2, of Grant Thornton's opinion on the Company's financial statements as of April 30, 2004 and 2003 and for the years then ended, and prior to completing a review of the Company's financial statements to be included in the Form 10-QSB for the period ended October 31, 2004. Grant Thornton believed that if the additional auditing procedures were performed and additional information was obtained there may be a material impact on the fairness or reliability of the Company's financial statements; however, due to Grant Thornton's dismissal, they did not conduct such procedures or obtain such information. The Company did not agree with Grant Thornton that the NASDAQ inquiry was material or that the NASDAQ inquiry impacted the financial statements, disclosure, or auditing scope or procedures. The Company's audit committee has discussed this matter with Grant Thornton, and Grant Thornton has also been authorized to fully respond to inquiries made by Hein & Associates LLP concerning this matter.

During the Company's past two fiscal years and through November 23, 2004, we did not consult Hein & Associates LLP regarding the application of accounting principles to a specific transaction, either contemplated or proposed, or the type of audit opinion that might be rendered on the Company's consolidated financial statements, or any other matter or reportable event that would be required to be reported in this Form 8-K.

We have provided Grant Thornton a copy of these disclosures and have requested Grant Thornton to furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether Grant Thornton agrees with the statements by the Company in this report. Grant Thornton's letter is attached as Exhibit 16.1.

Item 7.01 Regulation FD Disclosure

On October 14, 2004, we issued a press release providing guidance on the exercisability of our outstanding Class B and Class C common stock purchase warrants. A copy of the press release is attached with this report as Exhibit 99.1.

On October 15, 2004, we issued a press release announcing the debut of the NeutroTest prototype. A copy of the press release is attached with this report as Exhibit 99.2.

On October 19, 2004, we issued a press release commenting on recent market activity. A copy of the press release is attached with this report as Exhibit 99.3.

On October 19, 2004, we issued a press release announcing a webcast conference held on October 21, 2004, of our NeutroTest prototype. A copy of the press release is attached with this report as Exhibit 99.4.

On October 22, 2004, we issued a press release announcing the availability of our NeutroTest presentation to NATO on our website. A copy of the press release is attached with this report as Exhibit 99.5.

On October 27, 2004 we issued a press release announcing the naming of Charles E. Minter as Director of Commercialization for our Homeland Security and Defense Division. A copy of the press release is attached with this report as Exhibit 99.6.

On November 9, 2004 we issued a press release announcing that retired U.S. Navy Rear Admiral Cathal L. Flynn has joined our Homeland Security and Defense Advisory Board. A copy of the press release is attached with this report as Exhibit 99.7.

On November 12, 2004 we issued a press release announcing that Michael Caridi has joined our Homeland Security and Defense Advisory Board. A copy of the press release is attached with this report as Exhibit 99.8.

On November 22, 2004 we issued a press release announcing that our NeutroTest explosive detection product passes further business and technical milestones during executive review. A copy of the press release is attached with this report as Exhibit 99.9.

On November 28, 2004, the Company issued a press release announcing the appointment of the Company's vice president, Daniel Grady, Ph.D. to oversee the operations of the Company's wholly-owned subsidiary, Homeland Security and Defense Corporation, announcing the appointment of the Company's vice president Lindsay Gardner, to oversee the operations of the Company's life sciences division and a Nasdaq request for information. A copy of the press release is attached with this report as Exhibit 99.10.

On November 29, 2004 we issued a press release discussing that an Isonics Executive will present at a Southern California Investment Association Conference this week. A copy of the press release is attached with this report as Exhibit 99.11.

Item 9.01 Financial Statements and Exhibits

(c): Exhibits

16.1		Letter of Grant Thornton LLP, dated November 24, 2004 regarding the change in certifying accountant.
99.1		October 14, 2004 press release providing guidance on the exercisability of our outstanding Class B and Class C common stock purchase warrants.
99.2		October 15, 2004 press release announcing the debut of the NeutroTest prototype.
99.3		October 19, 2004 press release commenting on recent market activity.
99.4		October 19, 2004 press release announcing a webcast conference held on October 21, 2004, of our NeutroTest prototype.
99.5		October 22, 2004 press release announcing the availability of our NeutroTest presentation to NATO on our website.
99.6		October 27, 2004 press release announcing the hiring of a Director of Commercialization for our Homeland Security and Defense Division.
99.7		November 9, 2004 press release announcing that U.S. Navy Rear Admiral Cathal L. Flynn has joined our Homeland Security and Defense Advisory Board.
99.8		November 12, 2004 press release announcing that Michael Caridi has joined our Homeland Security and Defense Advisory Board.
99.9		November 22, 2004 press release announcing progress of our NeutroTest product.
99.10		November 28, 2004 press release announcing position appointments and Nasdaq request for information
99.11		November 29, 2004 press release announcing presentation at SCIA conference

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 1st day of December 2004.

		Isonics Corporation
		By:		/s/ JAMES E. ALEXANDER James E. Alexander President and Chief Executive Officer

QuickLinks

Item 4.01 Changes in Registrant's Certifying Accountant

Item 7.01 Regulation FD Disclosure

Item 9.01 Financial Statements and Exhibits

SIGNATURES
EX-16.1 2 a2147650zex-16_1.htm EX-16.1
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 16.1

December 1, 2004

U.S. Securities and Exchange Commission
Office of the Chief Accountant
450 Fifth Street, NWWashington, DC 20549

Re:: Isonics Corporation
File No. 001-12531

Dear Sir or Madam:

We have read Item 4.01 of Form 8-K of Isonics Corporation dated November 24, 2004, and agree with the statements concerning our Firm contained therein.

Very truly yours,

/s/GRANT THORNTON LLP

QuickLinks

Exhibit 16.1

EX-99.1 3 a2147650zex-99_1.htm EX-99.1
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 99.1

Isonics Provides Guidance on Exercisability of Warrant Classes

Class B and C Warrants Temporarily Not Exercisable

GOLDEN, CO (October 14)—Isonics Corporation (NASDAQ: ISON), provided guidance today with respect to various classes of warrants. Specifically, the Company noted that its Class B and Class C warrants are not presently exercisable due to the fact that the related Form SB-2 registration statement is not current. The warrants may still be traded on the Nasdaq SmallCap market and are listed under the symbols ISONL and ISONZ, respectively. The announcement was made by John V. Sakys, vice president and CFO of Isonics.

The Company indicated that it expects to file an updated Form SB-2 with the SEC within 10 business days. Upon effectiveness of the post-effective amendment, the Company will announce that the warrants are again exercisable.

A Class B warrant is exercisable for $1.50 and results in one common share and one Class C warrant. A Class C warrant is exercisable for $2.50 and results in one common share. Both warrants expire December 31, 2005. This announcement does not constitute the offer of any Isonics securities for sale.

Cautionary Statement

Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2004, and its quarterly report on Form 10-QSB for the three months ended July 31, 2004, both as filed with the Securities and Exchange Commission, which include the Company's cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission.

Contact:

Isonics Corporation
John V. Sakys, 303-279-7900
or
Investor Relations:
Trilogy Capital Partners, Inc.
Paul Karon, 800-342-1467
paul@trilogy-capital.com

Source: Isonics Corporation

QuickLinks

Isonics Provides Guidance on Exercisability of Warrant Classes
EX-99.2 4 a2147650zex-99_2.htm EX-99.2
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 99.2

Isonics Corporation Announces Debut of NeutroTest™Prototype

Explosive Detection Device to Receive First Public Demonstration Via
Online Conference on Thursday, October 21

GOLDEN, CO (October 15, 2004)—Isonics Corporation (NASDAQ: ISON), committed to the development of next-generation technology for the homeland security and semiconductor markets, has scheduled the premier public demonstration of a prototype of its NeutroTest™ explosive detection product. The presentation, which will be available to the public via the Internet, has been scheduled for Noon EDT, October 21. The announcement was made by Boris Rubizhevsky, president of Isonics Homeland Security and Defense Corporation, a wholly-owned subsidiary of Isonics.

"Due to the response we have received from investors and industry about Isonics' NeutroTest™ explosive detection device over the last several days, we have decided to accelerate the date of our public introduction to next Thursday," said Mr. Rubizhevsky. "We will utilize the worldwide platform of the Internet to better reach investors and decision-makers in the homeland security marketplace, so that we can clearly communicate the technical and functional details of the NeutroTest™ to the public. This unique online event will be the first in a series of Internet presentations Isonics Homeland Security and Defense will conduct as it develops its anticipated new technologies and services."

The October 21 presentation will include video footage of the functional operation of the NeutroTest™ prototype device, filmed September 24^th in the Berlin, Germany laboratories of IUT-Berlin, Isonics' development partner which is developing NeutroTest™ under a research and development contract with IUT Detection Technologies, an 85%-owned Isonics subsidiary.

The NeutroTest™ product is a portable, hand-held device designed to provide first-responders with a powerful tool for quickly and easily evaluating an explosive threat in the form of a suspicious package or purported explosive device. It was designed to be capable of detecting as little as 200 grams of TNT or other explosive material through 5 mm of steel.

The NeutroTest™ device uses a stream of neutrons to penetrate to the interior of objects, such as packages or suitcases, and interact with the materials inside. When interacting with neutrons, every element produces a unique data "signature," consisting of back-scattered neutrons, gamma rays and other information. NeutroTest™ analyzes the data streams and informs the operator via a readable display if the contents are potentially dangerous.

This neutron-based technology is distinct from the x-ray scanning systems commonly used in package and suitcase security inspections, and provides unique types of information about the packages or cases being evaluated. X-rays simply detect shapes and density, and provide pictures of the contents of containers. Neutrons have the ability to provide information regarding the nature of the chemical composition while x-rays do not.

Isonics is positioning the NeutroTest™ as a moderately-priced, portable product for use by first-responders in bomb squads, airports, police departments, fire departments, customs agencies and security services worldwide.

Online Conference

Investors interested in attending the online presentation must log onto www.trilogy-capital.com/isonics the day of the presentation. The presentation will be archived for viewing immediately following the debut presentation for a thirty day period.

About Isonics Corporation

Isonics Corporation has three business divisions: (1) Isonics Semiconductor, (2) Isonics Life Sciences, and (3) Homeland Security and Defense. Isonics is a world leader in isotopically engineered materials and through its semiconductor division produces isotopically pure silicon-28 chemicals and wafers for the semiconductor industry. Through advances in nanotechnology, the Company is also focused on research and development opportunities for further, value-added product and application development. Isonics' Life Sciences division markets and sells stable isotopes for the health care industry such as carbon-13 for diagnostic breath tests and drug design, and radioisotopes and stable isotopes, such as oxygen-18 for positron emission tomography (PET) imaging. Stable isotopes can be thought of as ultra pure materials. This high degree of purification provides enhanced properties as compared to natural materials. Our efforts in the Homeland Security segment are nascent at the present time as we proceed to develop further our neutron-based detection technologies. Additional information may be obtained at the Company's Web site at http://www.isonics.com.

Cautionary Statement

Contact:

Isonics Corporation
James Alexander, 303-279-7900
or
Investor Relations:
Trilogy Capital Partners, Inc.
Paul Karon, 800-342-1467
paul@trilogy-capital.com

Source: Isonics Corporation

QuickLinks

Isonics Corporation Announces Debut of NeutroTest™Prototype
EX-99.3 5 a2147650zex-99_3.htm EX-99.3
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 99.3

Isonics' Management Comments on Recent Market Activity

Tuesday October 19, 9:01 am ET

GOLDEN, Colo.—(BUSINESS WIRE)—Oct. 19, 2004—Isonics Corporation (Nasdaq:ISON—News), committed to the development of next-generation technology for the homeland security and semiconductor markets, commented about recent market activity with respect to the trading of its common stock. The comments were made by James E. Alexander, Chairman and CEO for the Company.

"Issues regarding homeland security and terrorism are a common topic in American media and the international investment community is highly sensitized to any announcement regarding products or services in the homeland security sector," said Mr. Alexander. "Notwithstanding that fact, the market's reaction over the last week to our various announcements was unanticipated. Quite simply, Isonics did not expect the significant trading activity that came in the wake of our recent announcements regarding formation of our homeland security division and the presentation of our NeutroTest(TM) prototype."

Mr. Alexander continued, "Given this trading activity, we also believe it important to note that no officers or directors of Isonics have sold any shares, warrants or other Isonics' securities during this period. Most importantly, we look forward to the webcast presentation of the NeutroTest(TM) prototype, on Thursday, October 21, which we believe will demonstrate the potential capabilities of NeutroTest(TM).

Mr. Alexander concluded, "Isonics stands behind the accuracy of our statements with respect to the technology. As we have noted in our various news releases, we wish to emphasize that the NeutroTest(TM) device is a prototype, and that there is no assurance that this or any other product developed by our homeland security division will achieve commercial acceptance. The homeland security market is highly competitive, with products and companies possessing far greater resources than Isonics, and which may bring competitive products to the marketplace."

Cautionary Statement

Contact:

Isonics Corporation
James Alexander, 303-279-7900
or
Trilogy Capital Partners, Inc.
Paul Karon, 800-342-1467 (Investor Relations)
paul@trilogy-capital.com

QuickLinks

Isonics' Management Comments on Recent Market Activity
EX-99.4 6 a2147650zex-99_4.htm EX-99.4
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 99.4

Webcast Alert: Isonics Corporation to Present First Public Demonstration
of NeutroTest™ Explosive Detection Prototype in Online Presentation

Webcast on Thursday, October 21, 12 noon EST

GOLDEN, Colo.—(BUSINESS WIRE)—Oct. 19, 2004—Isonics Corporation (Nasdaq: ISON) committed to the development of next-generation technology for the homeland security and semiconductor markets, issued a webcast alert for the first public viewing of operational demonstration of the prototype of its NeutroTest™ explosive detection technology. The demonstration will be shown via an online presentation.

What: Isonics NeutroTest™ video webcast.

When: Thursday, Oct. 21, at 12 noon EST

Where: www.trilogy-capital.com or www.isonics.com. Follow prompts to view webcast. Log on any time prior to the webcast.

Who: The demonstration is free of charge and may be viewed by anyone.

The webcast will demonstrate various functions of the prototype of Isonics' NeutroTest™ explosive detection device. The demonstration was recorded on September 24, 2004 at the laboratories of the Institut fur Umwelttechnologien GmbH (IUT-Berlin) in Berlin, Germany.

"We are glad to be able to provide this webcast for the public to demonstrate the capabilities of NeutroTest™," said James E. Alexander, Chairman and CEO of Isonics Corp. "The worldwide platform of the Internet will enable us to reach as many people as possible. As we've noted, NeutroTest(TM) is still in the prototype stage, and is not yet ready for commercial distribution, but we wanted to let the public know as much as possible about this powerful technology."

NeutroTest™ is based on Isonics' neutron-based detection technology. When development is completed, we anticipate that NeutroTest will be a small, lightweight and portable product for use by law enforcement and other first-responder personnel to safely detect the presence of potentially dangerous explosive materials concealed inside suitcases or other small packages.

About Isonics Corporation

Cautionary Statement

Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control and, in fact, the market for the Company's securities has been extremely volatile in price and volume recently. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2004, and its quarterly report on Form 10-QSB for the three months ended July 31, 2004, both as filed with the Securities and Exchange Commission, which include the Company's cash flow difficulties, historical operating losses and the lack of any assurance of earnings in the future, dependence on significant customers, and rapid development of competing technology, the early stage of the Company's NeutroTest prototype, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission.

Contact:

Isonics Corporation
James Alexander, 303-279-7900
or
Trilogy Capital Partners, Inc.
Paul Karon, 800-342-1467 (Investor Relations)
paul@trilogy-capital.com

QuickLinks

Webcast Alert: Isonics Corporation to Present First Public Demonstration of NeutroTest™ Explosive Detection Prototype in Online Presentation
EX-99.5 7 a2147650zex-99_5.htm EX-99.5
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 99.5

Isonics Corporation Makes NATO NeutroTest™ Presentation
Available to Public

Report Provides Explanation and Photographs of Prototype Explosive
Detection Device

GOLDEN, CO (Oct. 21, 2004)—Isonics Corporation (NASDAQ: ISON), committed to the development of next-generation technology for the homeland security and semiconductor markets, has made publicly available the complete presentation about its NeutroTest™ portable explosive detection technology and prototype scanner delivered at a conference of the North Atlantic Treaty Organization (NATO) in Spain earlier this week.

Dirk Rondeshagen, Ph.D., a research scientist with the Institut fur Umwelttechnologien GmbH (IUT-Berlin), presented the paper at the NATO conference, which was held Oct. 18-19 in Madrid, Spain. The symposium, entitled "Countering Improvised Explosive Devices," focused on advances in explosive detection technology and related concerns. Isonics' subsidiary, IUT Detection Technologies, Inc. ("IUTDT") acquired the NeutroTest technology from IUT-Berlin and, in June 2004, Isonics entered into research and development agreement with IUT-Berlin. IUT-Berlin owns 15% of IUTDT.

The 33-page presentation contains explanations and illustrations of neutron-based explosive detection technology, and descriptions of the NeutroTest™ prototype. The presentation also contains several photos of scientists demonstrating use of the prototype NeutroTest™, illustrating how the portable, handheld device can evaluate scan packages, suitcases and other objects or containers that could hold explosive materials. Of particular note is a practical field application where NeutroTest™ is used to investigate the presence and location of TNT in an abandoned TNT production vessel in the former East Germany.

The presentation can be viewed in its entirety at http://www.tri103.com/isonics/madrid.pdf. The readers should be aware that this is a technical presentation designed to be given with oral commentary. The text of the presentation itself may not be self-explanatory.

About Isonics Corporation

Cautionary Statement

Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2004, and its quarterly report on Form 10-QSB for the three months ended July 31, 2004, both as filed with the Securities and Exchange Commission, which include the Company's historical cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission. Isonics cautions investors that there are currently no commercial NeutroTest products, and no guarantee there will be. Isonics has made no NeutroTest sales and no government agency or other person has expressed an interest in purchasing NeutroTest. There can be no assurance that Isonics will be able to manufacture the NeutroTest for the market at a cost and with capabilities that meet the needs of prospective customers.

Contact:

Isonics Corporation
James Alexander, 303-279-7900
or
Investor Relations:
Trilogy Capital Partners, Inc.
Paul Karon, 800-342-1467
paul@trilogy-capital.com

Source: Isonics Corporation

This announcement may contain forward-looking statements made by senior management of Isonics that involve risks and uncertainties, such as statements about plans, objectives, expectations, assumptions or future events. These statements involve estimates, assumptions, known and unknown risks, uncertainties and performances, or achievements expressed or implied by the forward-looking statements. Actual future results and trends may differ materially from those made in—or suggested by—statements made in this announcement due to a variety of factors. Consequently, you should not place undue reliance on any forward-looking statements made in this announcement. For more information about Isonics and risks arising from investing in Isonics, you are directed to the Company's most recent Form 10-KSB filed with the Securities and Exchange Commission.

QuickLinks

Isonics Corporation Makes NATO NeutroTest™ Presentation Available to Public
EX-99.6 8 a2147650zex-99_6.htm EX-99.6
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 99.6

Isonics Corporation Names Charles E. Minter Director of
Commercialization for Homeland Security and Defense Division

Aviation Security and Advanced Medical Products Specialist to Accelerate Market Introduction of NeutroTest™ and other Homeland Security Technologies

GOLDEN, Colo.—(BUSINESS WIRE)—October 27, 2004—Isonics Corporation (NASDAQ:ISON—News), committed to the development of next-generation technology for the homeland security and semiconductor markets, has appointed product marketing veteran Charles E. Minter to the post of Director of Commercialization for the Company's Homeland Security and Defense division. The appointment was announced by James E. Alexander, Isonics Chairman and CEO.

Mr. Minter will direct the commercialization of Isonics' NeutroTest™ explosive detection prototype for the civilian and military markets, as well as all other products and services the Company will develop or acquire through its Homeland Security and Defense division. Mr. Minter will start work on November 1^st.

"Isonics is fully committed to making our prototype NeutroTest™ explosive detection device commercially available at the earliest possible time. We believe Charles Minter's background and expertise will be a key factor in accelerating the NeutroTest™ prototype from the laboratory to the marketplace, where technology like this is so desperately needed," said Mr. Alexander. "There is a critical need worldwide for effective explosive detection products that can help law enforcement, transportation and other first responders to safely and quickly evaluate packages and suitcases for the presence of concealed bombs and explosives."

Mr. Minter has extensive experience in business and regulatory aspects of the delivery of high technology and security products to the market. His professional background includes several years as manager of marketing, sales and deployment activities for markets on three continents for Invision Technologies, Inc., a maker of proprietary intelligence and aviation security technology. He was Vice President, Business Development and Field Operations for Cardiovascular Ventures Inc., the world's foremost provider of stand-alone cardio pulmonary facilities. Mr. Minter was Vice President, Operations and Regulatory Affairs for Vital Imaging Inc., a diagnostic medical company. He served as Chief Operations Officer and Vice President, Programs and Regulatory Affairs for MedAcoustics Inc., involved in the conversion of military defense technology into applications for health care and industrial uses. He most recently served as a consultant for governments and high-technology companies worldwide.

"I'm very pleased to be joining Isonics. The members of the management team are seasoned professionals with a long track record of bringing high-technology to the marketplace," said Mr. Minter. "I'm eager to get involved with an important product such as NeutroTest™, and I look forward to working on other new products and technologies that Isonics will attempt to bring to the homeland security marketplace."

About Isonics Corporation

Cautionary Statement

Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2004, and its quarterly report on Form 10-QSB for the three months ended July 31, 2004, both as filed with the Securities and Exchange Commission, which include the Company's historical cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission. Isonics cautions investors that there are currently no commercial NeutroTest products, and no guarantee there will be. Isonics has made no NeutroTest sales and no government agency or other person has expressed an interest in purchasing NeutroTest. There can be no assurance that Isonics will be able to manufacture the NeutroTest for the market at a cost and with capabilities that meet the needs of prospective customers.

Contact:

Isonics Corporation
James Alexander, 303-279-7900
or
Investor Relations:
Trilogy Capital Partners, Inc.
Paul Karon, 800-342-1467
paul@trilogy-capital.com

QuickLinks

Isonics Corporation Names Charles E. Minter Director of Commercialization for Homeland Security and Defense Division
EX-99.7 9 a2147650zex-99_7.htm EX-99.7
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 99.7

Isonics Names Retired U.S. Navy Rear Admiral Cathal L. Flynn to
Homeland Security and Defense Advisory Board

Former Naval Security and Intelligence Official Has Decades of Experience in Counter-Terrorism; Served as Civil Aviation Security Specialist for FAA

GOLDEN, Colo.—(BUSINESS WIRE)—November 9, 2004—Isonics Corporation (NASDAQ:ISON—News), committed to the development of next-generation technology for the homeland security and semiconductor markets, has named security and counter-terrorism expert Rear Admiral Cathal L. Flynn, USN (Ret.) to the Advisory Board of its Homeland Security and Defense division.

The announcement was made by Boris Rubizhevsky, president of Isonics' Homeland Security and Defense Corporation.

With the appointment, Rear Admiral Flynn becomes the first member of the newly-established Advisory Board to the Isonics Homeland Security and Defense division. The advisory board members will provide guidance and advice to Isonics in matters of technology, business and applications as the Company develops technologies and products for the homeland security marketplace.

RADM Flynn spent 30 years in active service in the U.S. Navy, predominantly in naval special warfare, joint special operations, counter-terrorism and international security affairs. From 1993 to 2000, he was Associate Administrator for Civil Aviation Security in the Federal Aviation Administration.

Following his promotion to Rear Admiral in 1985, RADM Flynn was assigned as Commander, Naval Security and Investigative Command and Assistant Director of Naval Intelligence for Counterintelligence and Anti-terrorism. He subsequently served as Director of Plans and Policy, U.S. Special Operations Command, and Deputy Assistant Secretary of Defense for Special Operations.

"As we develop technology and products for the homeland security marketplace, Isonics will benefit enormously from Rear Admiral Flynn's experience within both the civilian aviation and Defense arenas," said Mr. Rubizhevsky. "That a person of Admiral Flynn's background and technical expertise should join the Advisory Board is an important validation of the strength of our company and our homeland security programs."

RADM Flynn has served on committees of the National Research Council and the Defense Science Board. He holds MA and BAI degrees in Civil Engineering from the University of Dublin, Trinity College, and an MS degree in East Asian Studies from American University in Washington, DC.

"I am gratified to be able to continue serving my country and people around the world through the Isonics Homeland Security and Defense division," said RADM Flynn. "My career in security and intelligence has demonstrated the importance of high-technology in the fight against terrorism, and I believe the technology Isonics is developing can make a significant difference to the safety and security of citizens worldwide."

Warrant Exercises and Net Proceeds

The Company also provided information with respect to the current warrant exercises, receipt of proceeds from the exercises and its current cash position. As of Friday, November 5 and since September 30, 2004, warrants representing approximately 3.8 million common shares have been exercised resulting in cash proceeds of approximately $4.8 million to the Company. These warrants were previously issued pursuant to various financings dating back to 2002.

In addition, as previously announced, the Company noted that its Class B and Class C warrants are not presently exercisable due to the fact that the related Form SB-2 registration statement is not current. The Company has not yet filed its post-effective amendment on Form SB-2. The Company is working diligently to do so at the earliest possible time. The Class B and Class C warrants are still eligible for trading on the Nasdaq Small Cap market under the symbols ISONL, and ISONZ, respectively.

About Isonics Corporation

Cautionary Statement

Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2004, and its quarterly report on Form 10-QSB for the three months ended July 31, 2004, both as filed with the Securities and Exchange Commission, which include the Company's historical cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission. Isonics cautions investors that there are currently no commercial NeutroTest products, and no guarantee there will be. Isonics has made no NeutroTest sales and no government agency or other person has expressed an interest in purchasing NeutroTest. There can be no assurance that Isonics will be able to manufacture the NeutroTest for the market at a cost and with capabilities that meet the needs of prospective customers.

Contact:

Isonics Corporation
James Alexander, 303-279-7900
or
Investor Relations:
Trilogy Capital Partners, Inc.
Paul Karon, 800-342-1467
paul@trilogy-capital.com

QuickLinks

Isonics Names Retired U.S. Navy Rear Admiral Cathal L. Flynn to Homeland Security and Defense Advisory Board
EX-99.8 10 a2147650zex-99_8.htm EX-99.8
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 99.8

Isonics Names Michael Caridi, Business Leader and Security Expert, to
Homeland Security and Defense Advisory Board

Caridi Brings Extensive Background in Institutional Security Services and Government Contracts

GOLDEN, Colo.—(BUSINESS WIRE)—November 1, 2004—Isonics Corporation (NASDAQ:ISON—News), committed to the development of next-generation technology for the homeland security and semiconductor markets, has named security expert and entrepreneur Michael Caridi to the Advisory Board of its Homeland Security and Defense division.

The announcement was made by Boris Rubizhevsky, president of the Isonics Homeland Security and Defense Corporation.

Mr. Caridi is chairman of the board of Protection Plus Security Consultants, a New York based provider of advanced security and investigative services for leading businesses and institutions in healthcare, education, retail, manufacturing and the art world. He is chairman of real estate development firm Majic Development Group, currently developing the 538,856 square-foot Harlem Park office-retail-hotel project in New York, N.Y.

"We are delighted Mr. Caridi has agreed to serve on the Advisory Board of Isonics' Homeland Security and Defense division," said Mr. Rubizhevsky. "His combination of experience as a successful business leader and as an innovator in the security industry will be invaluable to Isonics as we proceed with development of products and services for the homeland security sector."

Mr. Caridi also has extensive background in international business, construction, marketing and distribution as well as major government and military contracts, including the demilitarization of the former USS Bennington, a US Navy Aircraft Carrier.

"I welcome the opportunity to add my knowledge, experience and enthusiasm to the exciting and important homeland security products Isonics is developing," said Mr. Caridi. "As a security professional and a businessman, I am well aware of the value of Isonics' technology, and I have been equally impressed by the quality of the management team."

About Isonics Corporation

Cautionary Statement

Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2004, and its quarterly report on Form 10-QSB for the three months ended July 31, 2004, both as filed with the Securities and Exchange Commission, which include the Company's historical cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission. Isonics cautions investors that there are currently no commercial NeutroTest products, and no guarantee there will be. Isonics has made no NeutroTest sales and no government agency or other person has expressed an interest in purchasing NeutroTest. There can be no assurance that Isonics will be able to manufacture the NeutroTest for the market at a cost and with capabilities that meet the needs of prospective customers.

Contact:

Isonics Corporation
Boris Rubizhevsky, 303-279-7900
or
Investor Relations:
Trilogy Capital Partners, Inc.
Paul Karon, 800-342-1467
paul@trilogy-capital.com

QuickLinks

Isonics Names Michael Caridi, Business Leader and Security Expert, to Homeland Security and Defense Advisory Board
EX-99.9 11 a2147650zex-99_9.htm EX-99.9
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 99.9

Isonics NeutroTest Explosive Detection Product Passes Further Business
and Technical Milestones During Executive Review

Division President Authorizes Production of New Informational Film to Demonstrate NeutroTest™ Capabilities and Applications to Market Constituency

GOLDEN, Colo.—(BUSINESS WIRE)—November 22, 2004—Isonics Corporation (NASDAQ:ISON), committed to the development of next-generation technology for the homeland security and semiconductor markets, has announced that its NeutroTest™ explosive detection prototype device has continued to meet progress milestones, following a recent executive visit to the Berlin-based laboratories where the neutron-based portable detection unit is under development. The announcement was made by James E. Alexander, CEO of Isonics.

Boris Rubizhevsky, president of Isonics' Homeland Security and Defense division, held meetings Nov. 15-18 with the management at IUT-Berlin, where he assessed the team's continued development milestones regarding NeutroTest™.

"Due to the continued high level of interest in homeland security companies and related products, as well as ongoing requests from shareholders for information regarding Isonics' homeland security and defense division and the status of the NeutroTest™ prototype, Isonics' management believes it is important to provide continual progress reports in the interest of maintaining transparency with respect to our activities toward commercialization of the technology," said Mr. Rubizhevsky.

Mr. Rubizhevsky also authorized commencement of production of an informational film on the NeutroTest™ explosive detection prototype device. The film, currently scheduled for completion next month, will be used for informational and marketing purposes to aid the Company's outreach to decision-makers in law enforcement, air travel security, first-responders as well as the defense sectors about capabilities and potential applications for the portable, handheld explosive detection device.

"We anticipate using this informational film in various ways as we approach the security constituency in both civilian and military sectors during the marketing phase of NeutroTest™," said Mr. Rubizhevsky. "The film and other materials we intend to produce will be designed to clearly illustrate to the customer population some of the potential applications Isonics envisions for NeutroTest™.

NeutroTest™ is being designed to serve as a modestly-priced portable detection device that will enable police officers, bomb squads, airport security personnel and other first-responders to quickly and easily evaluate suspicious objects, such as small suitcases, containers or other packages, to identify the presence of materials that may be indicative of potentially dangerous explosives. The device is based on neutron detection technology and in its next generations is expected to be able to identity drugs, and chemical and biological agents.

Isonics additionally wishes to reiterate that no Company officers have sold stock during the high levels of market activity of recent months.

About Isonics Corporation

Cautionary Statement

Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2004, and its quarterly report on Form 10-QSB for the three months ended July 31, 2004, both as filed with the Securities and Exchange Commission, which include the Company's historical cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission. Isonics cautions investors that there are currently no commercial NeutroTest products, and no guarantee there will be. Isonics has made no NeutroTest sales and no government agency or other person has expressed an interest in purchasing NeutroTest. There can be no assurance that Isonics will be able to manufacture the NeutroTest for the market at a cost and with capabilities that meet the needs of prospective customers.

Contact:

Isonics Corporation
Boris Rubizhevsky, 303-279-7900
or
Investor Relations:
Trilogy Capital Partners, Inc.
Paul Karon, 800-342-1467
paul@trilogy-capital.com

QuickLinks

Isonics NeutroTest Explosive Detection Product Passes Further Business and Technical Milestones During Executive Review
EX-99.10 12 a2147650zex-99_10.htm EX-99.10
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 99.10

Isonics Corporation Announces Appointment of Daniel Grady to Vice President for Commercialization in Homeland Security Division

CEO Comments on Veteran Isonics VP and Background in Commercialization of High-Tech Products, Nasdaq Request for Information and Warrant Exercises

GOLDEN, Colo.—(BUSINESS WIRE)—November XX, 2004—Isonics Corporation (NASDAQ:ISON—News), committed to the development of next-generation technology for the homeland security and semiconductor markets, has announced that Dr. Daniel J. Grady, longtime Vice President of the Isonics Life Sciences division, has been named to the post of Vice President, Product Development and Commercialization for the Company's homeland security division.

The announcement was made by James E. Alexander, Isonics' chairman and CEO.

Dr. Grady, who holds a Ph.D. in nuclear engineering from the University of Michigan, will oversee product development, engineering and regulatory compliance for Isonics' NeutroTest™ explosive detection device, and for other products expected to be developed through Isonics' neutron-based trace detection technology.

"Dr. Grady's blend of technical and marketing experience at major technology companies such as TRW and GE provide a depth of experience highly relevant to the goals in our homeland security division," said Mr. Alexander. "Dan has a deep background in the successful development of high-technology products in both the medical systems and nuclear power industries, and we're fortunate we can apply his knowledge and leadership in our homeland security division."

Dr. Grady joined Isonics in 1995. He was previously Vice President of Research and Development at Sopha Medical Systems, a medical diagnostic imaging equipment manufacturer. He has served as Marketing Manager at GE Nuclear Energy, and worked for GE Nuclear Medicine in England and the United States. He has also held the post of Engineering Analysis Section Head for TRW.

In related news, Isonics is seeking a new director of commercialization, a position that was to be filled by Charles Minter. Shortly after commencement of his engagement, Mr. Minter informed the Company that he had elected to accept the newly-offered position of interim CEO for his previous consulting client, a medical device company, and thus would terminate his arrangement with Isonics. The new director of commercialization will report to Dr. Grady.

Lindsay Gardner, Isonics' Vice President of Corporate Development, will temporarily assume responsibility for the Life Sciences division, working with Dr. Grady to assure a smooth transition for customers and suppliers.

Other Developments

In other developments, Isonics is responding to requests for information received from the Nasdaq Stock Market with respect to the significant trading volume and volatility that occurred in October following announcements related to the Company's Homeland Security and Defense division. Isonics is providing information and documents as requested and appreciates Nasdaq's inquiry which it believes will benefit Isonics and its shareholders. The Company also reiterated that no officers or directors of Isonics have sold any shares, warrants or other Isonics' securities during this period.

The Company also noted that since October 1 through 4:00 pm Friday, November 26, holders of warrants issued in relation to previous equity financings exercised their warrants providing in excess of $4 million in proceeds to the Company. As noted in the Company's 10-KSB filing for the fiscal period ended April 30, 2004, as of July 14, 2004 the Company had outstanding options and common stock warrants for the purchase of up to 9,950,958 shares of common stock at an average exercise price of $1.37 per share. A detailed description of the warrants is set forth in that filing. The proceeds generated from the exercise of these warrants are in addition to the $3.3 million in proceeds from a separate financing the Company announced on October 6, 2004.

"The receipt of these proceeds in addition to our $3.3 million in financing announced October 6, 2004, has created a much stronger Isonics and will give us additional resources to pursue a number of potentially attractive opportunities," stated Mr. Alexander. "We anticipate this capital will help support significant internal growth as well as growth through potential acquisitions in the expansion of the Company's activities in the new homeland security division as well as in the Company's semiconductor and health sciences divisions. While there are no assurances we will be successful in generating growth, having these significant resources provides much greater leverage for the Company to do so."

About Isonics Corporation

Cautionary Statement

Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2004, and its quarterly report on Form 10-QSB for the three months ended July 31, 2004, both as filed with the Securities and Exchange Commission, which include the Company's historical cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission. Isonics cautions investors that there are currently no commercial NeutroTest products, and no guarantee there will be. Isonics has made no NeutroTest sales and no government agency or other person has expressed an interest in purchasing NeutroTest. There can be no assurance that Isonics will be able to manufacture the NeutroTest for the market at a cost and with capabilities that meet the needs of prospective customers.

Contact:

Isonics Corporation
Boris Rubizhevsky, 303-279-7900
or
Investor Relations:
Trilogy Capital Partners, Inc.
Paul Karon, 800-342-1467
paul@trilogy-capital.com

QuickLinks

Isonics Corporation Announces Appointment of Daniel Grady to Vice President for Commercialization in Homeland Security Division
EX-99.11 13 a2147650zex-99_11.htm EX-99.11
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 99.11

ISONICS EXECUTIVE TO PRESENT AT SOUTHERN CALIFORNIA INVESTMENT ASSOCIATION CONFERENCE THIS WEEK

Dr. Hans Walitzki, Isonics Vice President, to Update Investment Community on Company's Recent Achievements and Initiatives

GOLDEN, Colo.—(BUSINESS WIRE)—November 29, 2004—Isonics Corporation (NASDAQ:ISON—News), committed to the development of next-generation technology for the homeland security and semiconductor markets, has announced plans to present at the Southern California Investment Association (SCIA) Conference Dec. 4, in Newport Beach, California. James E. Alexander, Isonics CEO, made the announcement.

Dr. Hans Walitzki, Isonics' Vice President, will discuss the Company's recent initiatives and achievements in its three business divisions: homeland security, semiconductors and life sciences.

SCIA's bimonthly conferences principally showcase emerging publicly held firms. The forums bring together more than 150 NASD member firms and a wide range of members of the investment community, including investment bankers, analysts, capital formation professionals and others.

"We are pleased for the opportunity to tell the Southern California Investment Association and the investment community at large about Isonics' achievements during the past year and the outlook for the coming year," said Mr. Alexander. "We look forward to updating our colleagues in the investment community about the Company's business and technological progress in our three business divisions, including our activities in the homeland security space and our ongoing efforts to commercialize our NeutroTest™ prototype explosive detection product. In addition, we will be providing overviews of our strategic progress in our Life Sciences division, which specializes in sales of stable isotopes for health care and other applications. We'll also discuss the area of advanced semiconductors, where we are a leading provider of next-generation Silicon-28 and silicon-on-insulator (SOI) wafer technology."

Mr. Alexander also noted: "Our October 2004 private placement and recent warrant exercises have provided additional resources to assist Isonics in continuing to build upon its strategic, operational and marketing activities in all three divisions. We are working to strengthen Company revenues and increase shareholder value for the near- and long-term."

About Southern California Investment Association

SCIA was founded to facilitate stock support and capital formation for select companies. Based in Newport Beach, Calif., the organization is a national alliance of more than 150 NASD member firms, investment bankers, investment advisors, analysts, capital formation services, investor relations, industry consultants, securities attorneys, media and accredited investors. The organization's goal is to assist its member network and to build exposure and support for small-to-medium listed and emerging-growth companies by providing a bimonthly forum. SCIA's forums showcase cutting-edge national and international presenting companies.

About Isonics Corporation

Cautionary Statement

Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2004, and its quarterly report on Form 10-QSB for the three months ended July 31, 2004, both as filed with the Securities and Exchange Commission, which include the Company's historical cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission. Isonics cautions investors that there are currently no commercial NeutroTest products, and no guarantee there will be. Isonics has made no NeutroTest sales and no government agency or other person has expressed an interest in purchasing NeutroTest. There can be no assurance that Isonics will be able to manufacture the NeutroTest for the market at a cost and with capabilities that meet the needs of prospective customers.

Contact:

Isonics Corporation
James Alexander, 303-279-7900
or
Investor Relations:
Trilogy Capital Partners, Inc.
Paul Karon, 800-592-6067
paul@trilogy-capital.com

QuickLinks

ISONICS EXECUTIVE TO PRESENT AT SOUTHERN CALIFORNIA INVESTMENT ASSOCIATION CONFERENCE THIS WEEK
GRAPHIC 14 g102448.jpg G102448.JPG begin 644 g102448.jpg M_]C_X``02D9)1@`!`0$!L`&P``#__@`S35),3%]'4D%02$E#4SI;25-/3DE# M4UU)4T].24-37T-/4E!?0TU92U],3T=/+D504__;`$,`!P4&!@8%!P8&!@@( M!PD+$@P+"@H+%Q`1#1(;%QP<&A<:&1TA*B0='R@@&1HE,B4H+"TO,"\=(S0X M-"XW*BXO+O_;`$,!"`@("PH+%@P,%BX>&AXN+BXN+BXN+BXN+BXN+BXN+BXN M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+O_``!$(`%@!&@,!(@`" M$0$#$0'_Q``=```"`P$!`0$!````````````"`4&!P0#"0$"_\0`1Q```0,# M`@,%!04$!P4)`````0(#!``%$082!R$Q$T%1<8$(%#)AD14B-G2A(T)RL3=2 M8H*2HL$6&$.RLR8S8W-UPM'A\/_$`!H!`0`"`P$````````````````#!`$" M!0;_Q``G$0$``@$#`@4%`0```````````0(#!!$A!3$2(D%1<1,R,['1D?_: M``P#`0`"$0,1`#\`AZ***MO*BBBB@****`HHHH"BBB@*8K0WX1M'Y9-+J.?2 MF*T-^$;1^63467LZ/3?R3\)^BBBH79%%+'?O:'OL*^7&'!LUKA%!.4444!111 M0%%%%`4444!1110%%%5;B3J9>D-&7*_LMLNOQDH#3;N=JU*6$@''/OSZ4%IH MI:=+\>]57W4EKLR+%:A[[*;8*DAS*4J4`3\7<,GTIEJ`HHHH"BBB@****!5J M]X421.E-1(C*G7W5;4(2.9->%;#PPL\:UV1S44\H0X^DE+BS@-,COSW9QGRQ M5FUMH>EE(V&RQ0/% M((/U!S53NW%..T^INU6Y4A`..V>7L"O)(&<>>*+;Q5BK6$W*UNLI)^-A>\#T M.#]*BF+SRZ=,FDKY8V_QTW?A?:WPI=KE/1'.Y"_VB/UYCZFLXO\`I:]6(E4V M(3'!P)#7WFSZ]WKBM\M-YMEX8[:W3>XYA)^\GS'45W+2E:2E:0I*A@@C(( MI%YCNVR:+%DC>G'P5BBMLU)PXM=QW/VPBWR3SVI&6E'YI[O3Z5G%UT5J.V+5 MOMRY#8Z.QOV@/H.8^E2Q>)VT7/54-MQE+C#.7G0H9&$C MEG^\14?"TY?9KP9CVF65'O6T4)'F58`K7M,6.+HFP2Y\]Q"Y)1VDAQ/0`=$) M]?J36+VVAMI<%K7\5HXAF'$$QSJ^XIC,H:;;4E!"$@`J"1DX'SK9=#?A&T?E MDTODZ4[-FR)CQRZ^XIQ7F3FF#T-^$;1^636N2-JPLZ&WBS6M[_U/U$:LN2;/ MIF[W59($2(Z]R[RE)(_7%2]95[1UU^S>&,R.E0#EP?:C)Y\\9WJQZ(_6H76) MU`BO3[A&AL@J>DNI:0.\J40!^IKZ(VZ(U`M\6"S_`-U':0TCR2`!_*DEX'VH M7?B?8FEH"FV'3*7G_P`-)4/\P36S>T9Q&NE@7&TM8I*HLB0QV\J2VK"TH)(2 MA)_=)P23UQC%!KE]UGI6P.=E>-00(CPZM./#M!_=&3^E>%DU[HV^2!%M>H[? M(D*.$M!W:M7DE6"?2E.X6<,IO$9=PDF\-0F8JDAQQ:"ZXM:LGXW8,*U3+JPWM4W,AL**%@\_0CO%`[E?A(`))P!51X;R[PGA]:Y&JD. MQ;BPPH2C*^ZH!"E`*7GQ2`232R<6^+%UUA<7[9:)#T73Z%%MMILE*I7=N7CF M0>Y/3&,\Z!G+GQ&T-:WS'F:IMJ'4\E(0]VA2?`[E+9IOV>+];?#>*=P;D M24-J*?'"B#CD:@>%FIW-7:&MEZD8][6@M2-HP.T0=JCCNSC/K2JQ>(#L-@X=D(DH4VW_$H'`ZCK4`QQ+T M$_-$)O5=L+Q5M&7L))_B/W?UI;N&O#+5.N]-(2N["UZ<1(6ML*05=N[@!2P@ M$!6,!.XGET'?5(XB:.G:&U&NR39#

/9/M01:[_>UH&77F MXK:L*LUZYR-(ZLMWASD)^+L'0HI\ MQU'K2IZ)X'7W5&E!?SXJ.1L![N1Y:3X@XP10?0RH6^ZHT[I].;U>X,%1&0AYX)61\D]3Z"LQXW<2 MIFG=)VE-E)CW*]-=JAWJ8[6U))']HE0`/F:P'ASHJY\3-0S&5W=+"VV^WDRI M&77%95CD,Y4<]Y./TH&XMG$?0MSDIC0]46U;RCA*%N]F5'P&[&35NR*2W6O! MC5NG[HB+:XDF^Q7&]Z9$2,K[O,C:H<\'U/(U[QHO'&+':C1XVJ6V6D!#:$I7 MA*0,`#TH+*RTI]YMA`)6XH(2!XDXK3N*L[W"!;--15%+(;"W`.64I^ZD?4$^ M@K,XS[D:2S):(#K2TK02,@$'(Y5V7R[S;Y<%3YZTJ>4D)PA.$@#H`*LS&\P\ MY3)%<=JQWG](ZBNNWVVX7)PMV^$_)6GJ&D%6/,]U32]#ZJ0UVIL[A'@E:"KZ M9S6=X1UQWM&\1,H"'*DPI"),1]QA]'PN-JP16E:;XG+1MCW]G>GI[RPGG_>3 M_J/I6Y1']LA1^I!-1SB M]G0IU*-O/4P/6JC<+G<;DH+GSI$DCIVKA4!Y#I7\VR#(N=PCP(J07WU[$;C@>9^5; M5I$7^*F2I+?:)NHN? M%"X-(5N;@M-14D>(3N5_F61Z5"["U>RG:>WU)>;RI&4Q(J6$JST4XK/\D'ZU M9?:"X87W45W9U-IZ/[XI,<,R8J5`.?=)PI(/Q3M<<#80^@?U@1@*Q MX$<_$5IFIN,G#.YZ5DI?4JX./L*`M[L115N(Y`E0VC![P>[EFE:TW8KGJ2\Q MK/:8RGY4A6T`#DD=ZE'N2.I-`W''W4`A\*9+T%T%-U4U';^Q2PX<#F6T(+ M:CCY`Y\@:7CA'JJ)H[7$*\7!M:X6U;+Q;&5(2L8W`=^#@X\,T#V=U(QQMN#= MRXI:B?94%(0^&`?FVA*#^J33`:QX]:2@V5Y6FY:[E=%HPRCL%H0VH]%+*@.0 MZX&2?EUI:!G_9^B*M/">%* MD@H#ZWI9![D;B`?4)SZTH%XFNW:\S;BL$NS)"WB,Y.5*)_UIUN)3\;27"6[M M0$]BS&MXAQT@X*=P#:OM/VT@*0[-;+@(SE"3N4/HDT#Q: M0M:;)I:T6E+8;,2(TTI(_K!(W'U.32D^T9@P*!I_9DMGN7#DS5-[5SY MCKH4>JDIP@?JE5+SQHNOVQQ-O\A*PIMN1[L@IZ8;`1_-)INM'16M*<-K6T\$ MI3`MJ77NX;@C>L_4FD6=6_=;JMS:52);Y.!SRI:O_DT#:\.%_P"R'`'[62K: M^(4B>"1^^K=L_P#92EV^.[=;Q&B%PEZ9(0V5GF=RU`9^IIX]5:;4[PMN&F80 M*G&[48[*4)^)2$#:`/F4_K21:=G(M6H[7>O[M8KQ@XU6:=I MI=ET=->>E3,!Z6A"VNP1G)`*@"5'IRZ#/.J[[/-LU)J+5B;S.N=R-!HW'SAM<]6PK9/TZTVY,MR%-&)N".T:."-N<`$$=. M\'Y4K\F!J;25P0Z_&N5GFMG"'"E;*@?DKE^AK7=4<<]>6?4=UM0C6Q"8DIUE M*7(RMVU*B!G[_ABM'B\;N'L_2[3E\D%4M3`$FWJAJ7N7C[R1D%)!.<9/0\Z# M'M)\=]9V=]I%V>;O$('"T/I"7=OR<'?Y@TS%OX@Z1FP(TU%X9;3(:2Z$.*0I1*4#QP,#TIJ[/P5@-6B`U.GO" M6B.VEX-X*0L)&['RSF@SNK1H;2[FI+BH.J4W`8P7UCJKP0/F?T%5?ISK:6IC M&A=!Q"6DJG/IREO^NZH9)/R`_EBK-YF.SSVFQUM:;7[0NL"%"MD5$6%';CL( MZ(0,#_[/SKJ!!&1TI9[M>+G=Y"G[A-=>4>B2K"4^21R%?MMO5VM;@7`N$AG' M[H62D^:3RJ/Z4^Z['4:Q.T5X,E)C1Y;*F)+#;S2N10XD*!]#5`U%PS@2]S]E M=$)X\^Q5E31\N]/ZCY5P:^ M!FCKW>)UWFR;N94Q];[NR0@)W*.3@;.0K5JX+E>+3:BV+G=(4+M/@]Y?2WO\ MMQ&:A==SZ6L$#3%AAV*V!P1(J2E!<(*CDDDD@#)))[JHFN."NDM53G;FGWBV M7!T[G'(A&QQ1ZJ4@C&?F,9[ZU!M:'$)<;4E2%#*5).01XUS7"Y6^V,A^Y3HT M-DG':2'4MISX94108="]FZP-OI5,U#<7V1U0VVALGUY_RK6M):,TWI&,IBPV MMJ,5C#CO-3KG\2SS/ETJ:@S8=PCIDP);$J.KX76'`M)\B.5?LN7%A-!V9)9C MMD[=[JP@9\,F@]5H0XA2%I"D*&"DC((\*QW5'`'2%WEKEVUZ59W%JRIJ/M6S MZ(/P^0./E6NLS(C[SS#$IEQYG':MH<"E(STR!TSW9K^7Y\&.^F._,CM/J&Y+ M:W4I41SY@$Y[C]*#$K5[.6F8\@.7*\W&:VGGV2`ED'S(R<>6*V+3]@LVG("; M?9+2X$GP.TG%=M!7M M;:3MNL[+]C75V2W%+J73[NL(42G.!D@\N=5C1W!_2FD+\S?+6[<5RV4+0@2' MDJ2-PP3@)'/&>^KJB_6-R>;;>J<%;3&3)07,^&W.[ M<)V[;[L92.TW>&W.//Y5=+LN2BU35PE-IE M)8665.G"`O:=I/RSC-!C%F]G32T22EZZ72X7!"2"&1M92KY'&3]"*V:TVRWV M>`S;K7#9B1&1A#32=J4__O&J]PWEZDF:>4]JF3;G[AVZP%P%I6WLP,#*>6AW(@`RXJ@E2\#` MW@@A6/'K\ZH;'LV61+R2_J2X.,YYH0RA"B//G_*MTMUQM]S8]XMLZ-,9!QVD M=U+B<^&037O(?8C,J?D/-LM)^);B@E(\R:"JZ,X>Z4T:G=9;:E,HIVJEO'M' ME#^(]!\A@5;JC?MVR>\LQ/MB![R^`IIGWE&]P'H4C.3Z5)4"O6]#3EPBH?6$ M,J>0'%$X"4[AD_2KAQ5NS%QOK,>)(0]'BL[BK6W.[S,9 M)BDTCU%%%%91BN^TW:Y6A_M[=,H M!!Z=M&YCU2?]#5K9U[I1QL+-V0C/[JVU@CTQ2_T5'..%VFORUC:>6S7OB=:H M[2D6EIR8_P!REI*&QYYYGT'K63WBZSKQ.7-GOEUU7(=R4#P2.X5PT5M6L1V0 MYM3DR_=/`IBM#?A&T?EDTNM,5H;\(VC\LFM,O99Z;^2?A/FELLUJM>L^,FOF M-8)$AJ$PZW'#JR`PVE82%)\,)Y^I-,G5"U;PLTKJB[+N\M$R+.=;[)YV$_V1 M?3C&%C!!Y#'EUJ%V7IPCB6*!I(0M.:A>O5M9?6EM]W_AD@$H'(9\,B@R[AFV MG3_'G56F;&%-V+L"XJ.E1*&U@-D$>16I/KCNJ=]J+^C=@XZ7)G_D[GW`5TZUTE:=9V=-HO27C%2\EX=BYL5N`( M'/']HT$/PMT9:-*V1$JW^\.3+DPR[,??=*RZO:3GP'-9K*^-,&![=\/K3#PX[<2(Q%9SV;+:6TY.3@#`_E6*<4-'S=2< M8=+O/6:3,L0B!J6\A)V(^\X>:AT/,'Z4$),M\+1WM#:>@:49$6/.C)3,B,YV M`*W@Y&?!(5\B,UJ7&>X7&V<,K],MBEHE!E*-[9(4A*EI2I0(Y@A)//NK]TEP MRTSI>\.7N()LNYK24B3.D%Y:`1@@OZUI[ M3;;+2&FD)0VA(2E"1@)`Z`#N%`KND='VG67&/7,"]&0J#'E/O]@TZ6PXOMBD M%6/`*5]:96]2(MOLMS"G% M*.2HEM.2?.J,UP,T,B,_%*;FY&<)4AI

@.GN+_P#TU56M2\+]-ZAU&-22'+C%N6Q*%.PY):W@#`SR)ZU4[^V&[EUK1N/']$^H?_+:_P"JBI+1W#O36DILBXV]F1(N M4@$.39CQ==(/49/3IX9/?4WJ>Q0-36.78[F'##E`!P-KVJY*"A@^8%`KFKM+ M62W\"=+ZEB0@U>77V^TEA1WK"@X<'GT&U./#%-/IQYR1IZU2'EE;KL-E:U$Y M))0"35>NG#K3MST=!T?*3*-KA*2IH)>PO*0K&58Y_$:MD&*U!A1X3&>QCM): M1N.3M2,#)\A0*[1115MY844448%%%%`44449%%%%&!3%:&_"-H_+)HHJ++V= M'IOY)^$_1114+LBBBB@****`HHHH"BBB@****`HHHH"BBB@****`HHHH"BBB '@****#__V3\_ ` end

-----END PRIVACY-ENHANCED MESSAGE-----